Renal cell carcinoma: the population, real world, and cost-of-illness

Renal cell carcinoma: the population, real world, and cost-of-illness

Abstract Background The RCC treatment landscape has evolved dramatically over the past decade. The purpose of this study is to present a real-world data estimation of RCC’s cost-of-illness for this tumour’s clinical pathway. Methods This investigation is a population-based cohort study using real-wo...

Full description

Bibliographic Details
Main Authors: Alessandra Buja, Giuseppe De Luca, Maura Gatti, Claudia Cozzolino, Massimo Rugge, Manuel Zorzi, Mario Gardi, Matteo Sepulcri, Davide Bimbatti, Vincenzo Baldo, Marco Maruzzo, Umberto Basso, Vittorina Zagonel
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Urology
Subjects:
Renal cell carcinoma
Cost-of-illness
Economic impact
Real-world data
Online Access:https://doi.org/10.1186/s12894-022-01160-y

Internet

https://doi.org/10.1186/s12894-022-01160-y

Similar Items